Crispr Therapeutics Ag (CRSP)

Investing Cash Flow

-$548.43M

TTM · Period ending: · USD

CRSP logo

CRSP Investing Cash Flow

Latest reported-$548.43M
CRSP TTM Cash from Investing (-$1.15M → -$548.43M)
High-resolution chart · PNG

CRSP investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Crispr Therapeutics Ag Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-548,429,000
-422,793,000
-31,805,000
36,824,000
-5,554,000
-202,436,000
-280,481,000
-467,762,000
-184,810,000
159,018,000
374,647,000
280,568,000
246,684,000
-26,311,000
-258,655,000
-91,839,000
-744,483,000
-982,047,000
-1,035,430,000
-1,230,958,000
-996,108,000
-706,077,000
-541,170,000
-329,869,000
-2,000,000
-569,000
1,325,000
-6,732,000
-4,966,000
-3,315,000
-2,773,000
-1,978,000
-4,777,000
-5,584,000
-8,314,000
6,663,000
8,648,000
8,931,000
31,884,000
16,609,000
17,569,000
18,514,000
-1,154,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.